Xiangrui Li Selected Research

Infections

1/2024	Identification and characterization of the receptors of a microneme adhesive repeat domain of Eimeria maxima microneme protein 3 in chicken intestine epithelial cells.
12/2023	Inhibitory effect of Eimeria maxima IFN-γ inhibitory molecules on the immune function of T cell subsets in chickens.
6/2022	Recombinant dynein light intermediate chain of Haemonchus contortus affects the functions of goat immune cells in vitro.
5/2022	Identification of excretory and secretory proteins from Haemonchus contortus inducing a Th9 immune response in goats.
1/2022	Protective efficacy induced by Eimeria maxima rhomboid-like protein 1 against homologous infection.
5/2021	The immunogenic maturation of goat monocyte-derived dendritic cells and upregulation of toll-like receptors by five antigens of Haemonchus contortus in-vitro.
5/2021	Poly (D, L-lactide-co-glycolide) delivery system improve the protective efficacy of recombinant antigen TA4 against Eimeria tenella infection.
2/2021	Rhomboid protein 2 of Eimeria maxima provided partial protection against infection by homologous species.
1/2021	Protection studies of an excretory-secretory protein HcABHD against Haemonchus contortus infection.
1/2021	Dynamic Expressions of TIGIT on Splenic T Cells and TIGIT-Mediated Splenic T Cell Dysfunction of Mice With Chronic Toxoplasma gondii Infection.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiangrui Li Research Topics

Disease

36	Infections 01/2024 - 10/2010
18	Coccidiosis 12/2023 - 10/2008
17	Body Weight (Weight, Body) 01/2020 - 10/2008
9	Neoplasms (Cancer) 02/2023 - 02/2018
8	Toxoplasmosis 01/2022 - 11/2015
6	Inflammation (Inflammations) 01/2023 - 10/2016
4	Coinfection 12/2023 - 06/2015
3	Lung Neoplasms (Lung Cancer) 10/2022 - 02/2018
3	Persistent Infection 08/2022 - 08/2020
3	Schistosomiasis (Bilharziasis) 12/2015 - 12/2010
2	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2023
2	Weight Loss (Weight Reduction) 12/2023 - 01/2022
2	Malnutrition (Nutritional Deficiencies) 11/2022 - 10/2022
2	Cachexia 11/2022 - 12/2021
2	Starvation 01/2021 - 12/2020
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2019
1	Insulin Resistance 03/2024
1	Hypothyroidism 01/2024
1	Asthma (Bronchial Asthma) 01/2024
1	Cataract (Cataracts) 01/2024
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2024
1	Allergic Rhinitis 01/2024
1	Rheumatoid Arthritis 01/2024
1	Ulcerative Colitis 12/2023
1	Colitis 12/2023
1	Adenocarcinoma of Lung 02/2023
1	Presbycusis 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 11/2022
1	Cellulite 11/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022
1	Abdominal Obesity 10/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2022
1	Cysts 08/2022
1	Trichinellosis 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022

Drug/Important Bio-Agent (IBA)

25	AntigensIBA 12/2023 - 10/2010
23	VaccinesIBA 12/2023 - 11/2006
21	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2011
20	DNA VaccinesIBA 12/2023 - 10/2008
8	CytokinesIBA 12/2023 - 02/2011
6	Recombinant ProteinsIBA 12/2023 - 11/2012
6	Interleukin-2 (IL2)IBA 04/2017 - 11/2006
5	Combined VaccinesIBA 12/2023 - 06/2015
5	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2022
5	Subunit VaccinesIBA 01/2022 - 09/2015
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2022
4	CholesterolIBA 04/2024 - 10/2022
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2010
3	EpitopesIBA 12/2023 - 06/2015
3	EnzymesIBA 01/2023 - 02/2013
3	Interleukin-9 (Interleukin 9)IBA 05/2022 - 01/2020
3	AntibodiesIBA 02/2020 - 12/2012
2	Messenger RNA (mRNA)IBA 12/2023 - 01/2023
2	Interleukin-17 (Interleukin 17)IBA 12/2023 - 11/2019
2	ImmunosorbentsIBA 01/2023 - 08/2019
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	AlbuminsIBA 01/2022 - 12/2021
2	InsecticidesIBA 01/2021 - 12/2020
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 12/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 01/2021
2	Interleukin-4 (Interleukin 4)IBA 04/2020 - 03/2020
1	HDL CholesterolIBA 03/2024
1	LigandsIBA 01/2024
1	P-2 (P 2)IBA 01/2024
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 12/2023
1	InterleukinsIBA 12/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2023
1	interleukin-21 (interleukin 21)IBA 12/2023
1	Dextran SulfateIBA 12/2023
1	Interleukin-10 (Interleukin 10)IBA 12/2023
1	Sirtuin 3IBA 12/2023
1	Orphan Nuclear ReceptorsIBA 12/2023
1	honokiolIBA 12/2023
1	Arsenic Trioxide (Trisenox)FDA Link 02/2023
1	Sirtuin 1IBA 01/2023
1	6-methyladenineIBA 01/2023
1	N-methyladenosineIBA 01/2023
1	4-toluenesulfonyl fluoride (TSF)IBA 11/2022
1	LipidsIBA 10/2022
1	Triglycerides (Triacylglycerol)IBA 10/2022
1	oxidized low density lipoproteinIBA 10/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2022
1	HDL LipoproteinsIBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 10/2022
1	ChemokinesIBA 06/2022
1	Carrier Proteins (Binding Protein)IBA 05/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	GlobulinsIBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 05/2021
1	ribosomal phosphoprotein P2IBA 04/2021

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2024 - 12/2010
2	Nanospheres 05/2021 - 01/2021
2	Therapeutics 02/2018 - 01/2018
1	Immunotherapy 01/2022
1	Immunomodulation 05/2021